Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway
Authors:
- Liyan QuLQLiyan Qu
- Zhengming YangZYZhengming Yang
- Huimin TaoHTHuimin Tao
- 1 July 2012
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 79 (1) , 98-100
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Provincial Natural Science Foundation of China (Y206257)
This publication has 31 references indexed in Scilit:
- Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot StudyClinical Orthopaedics and Related Research, 2009
- COX-2 Expression Correlates With Survival in Patients With Osteosarcoma Lung MetastasesJournal of Pediatric Hematology/Oncology, 2008
- Celecoxib, a cyclooxygenase‐2 inhibitor, induces apoptosis in human osteosarcoma cell line MG‐63 via down‐regulation of PI3K/AktCell Biology International, 2008
- Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routesCarcinogenesis, 2005
- Cyclooxygenase-2 Expression Does Not Correlate With Outcome in Osteosarcoma or RhabdomyosarcomaJournal of Pediatric Hematology/Oncology, 2003
- Cyclooxygenase-2 Expression in Pediatric SarcomasPediatric and Developmental Pathology, 2002
- COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cellsHepatology, 2002
- Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialProceedings of the National Academy of Sciences, 1997
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Anchorage dependence, integrins, and apoptosisCell, 1994